In CRC, ADAR1 enhances tumor progression through AZIN1 editing, stabilizing c-Myc and promoting IL-8–mediated angiogenesis (91), while also activating FAK/AKT signaling and inhibiting ferroptosis (9). Here, AKT1 is linked to neoplasm.